Select Medical Sees FY24 EPS $1.96-$2.20 Vs $2.03 Est.; Revenue $6.9B-$7.1B Vs $6.97B Est.
Select Medical Sees FY24 EPS $1.96-$2.20 Vs $2.03 Est.; Revenue $6.9B-$7.1B Vs $6.97B Est.
Business Outlook
商业展望
Select Medical is reaffirming its 2024 business outlook for revenue and adjusting its 2024 business outlook for Adjusted EBITDA and fully diluted earnings per share, which was provided most recently in its February 22, 2024, press release. Select Medical is also issuing its business outlook for adjusted earnings per share. Select Medical expects revenue to be in the range of $6.9 billion to $7.1 billion, Adjusted EBITDA to be in the range of $845 million to $885 million, fully diluted earnings per share to be in the range of $1.95 to $2.19 and adjusted earnings per share to be in the range of $1.96 to $2.20. Reconciliations of full year 2024 Adjusted EBITDA expectations to net income and adjusted earnings per share to fully diluted earnings per share are presented in table VIII of this release.
Select Medical重申了其2024年的业务收入展望，并调整了其2024年的业务展望，包括调整后的息税折旧摊销前利润和全面摊薄后的每股收益，这些前景最近在2024年2月22日的新闻稿中公布。Select Medical还发布了调整后每股收益的业务展望。Select Medical预计，收入将在69亿美元至71亿美元之间，调整后的息税折旧摊销前利润将在8.45亿美元至8.85亿美元之间，全面摊薄后的每股收益将在1.95美元至2.19美元之间，调整后的每股收益将在1.96美元至2.20美元之间。本新闻稿的表八列出了2024年全年调整后息税折旧摊销前利润预期与净收益以及调整后每股收益与全面摊薄后的每股收益的对账情况。
译文内容由第三方软件翻译。